Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma

Background/Aim: Little is known about the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine plus S-1 (GS) for patients with resectable pancreatic ductal adenocarcinoma (R-PDAC). The aim of this study was to investigate differences in the long-term outcome of patients with R-PDAC undergoing...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:In Vivo
Asıl Yazarlar: SUZUKI, TAKASHI, MORI, SHOZO, SHIMIZU, TAKAYUKI, TAGO, KAZUMA, HARADA, NOBUHIRO, PARK, KYUNG-HWA, SAKURAOKA, YUHKI, SHIRAKI, TAKAYUKI, ISO, YUKIHIRO, AOKI, TAKU, KUBOTA, KEIICHI
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: International Institute of Anticancer Research 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899096/
https://ncbi.nlm.nih.gov/pubmed/31662534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11700
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller